| abstract |
The present invention relates to an oral dosage form comprising one or more biologically active agents, a formulation aid and magnetizable particles, wherein the oral dosage form of the invention has two or more phase compositions, said phases being administered orally Wherein the magnetizable particles are present in the formulating adjuvant and are present in a magnetized state, the magnetized particles being present in at least two phases of the dosage form to generate a magnetic field, After administration, they dissolve at different times in the body, and the magnetic field strength for time, position, and body movement can be determined using a detection system and evaluated using a computer based evaluation system. |